Wednesday, July 23, 2025 12:00:23 AM
Prasad has some advice for the parents of DMD boys.
Amazing pick for the FDA. Let's face it, this guy is NOT meant to be in the position he now holds at the FDA. How on earth was he ever chosen!?
This is crazy. He is crazy.
New FDA official Vinay Prasad is pretty sure that soon after your demise, your loved ones will not remember you existed. pic.twitter.com/wKzQZS8J7w
— fipco-bio (@FipcoB) May 6, 2025
Amazing pick for the FDA. Let's face it, this guy is NOT meant to be in the position he now holds at the FDA. How on earth was he ever chosen!?
This is crazy. He is crazy.
Recent SRPT News
- When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech • InvestorsHub NewsWire • 04/20/2026 01:00:00 PM
- When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/31/2026 08:05:00 PM
- Sarepta shares jump after early clinical data from siRNA programs • IH Market News • 03/25/2026 03:31:46 PM
- Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1 • Business Wire • 03/25/2026 12:05:00 PM
- Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1 • Business Wire • 03/24/2026 08:05:00 PM
- Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53® • Business Wire • 03/19/2026 12:30:00 PM
- Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne • Business Wire • 03/16/2026 12:33:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2026 12:09:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2026 12:05:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2026 12:03:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2026 12:01:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 12:08:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 12:07:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 12:04:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 12:01:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 01:07:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 01:05:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 01:04:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 01:00:04 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 12:02:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2026 01:05:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2026 01:03:03 AM
- Sarepta Therapeutics Announces Call for Applications for the 9th Annual Route 79, The Duchenne Scholarship Program • Business Wire • 02/27/2026 02:00:00 PM
- Sarepta Therapeutics to Present New Long-Term and Safety Data Across Gene Therapy and Exon-Skipping Programs at 2026 Muscular Dystrophy Association Clinical & Scientific Congress • Business Wire • 02/26/2026 01:30:00 PM
